Apolipoprotein E is immunochemically localized to the senile plaques, vascular amyloid, and neuroflbrillary tangles of Alzheimer diwase. In 
previously associated with linkage of late-onset familial Alzheimer diseas. Analysis of apolipoprotein E alleles in Alzheimer disease and controls demonstrated that there was a highiy significant assocition of apolipoprotein E type 4 alele (APOEe4) and late-onset familil Alzheimer disea. The alele frequency of the APOE-e4 in 30 random affected patients, each from a different Azheimer disease family, was 0.50 t 0.06; the aUlele frequency of APOE-e4 in 91 age-matched unrelated controls was 0.16 ± 0.03 (Z = 2.44, P = 0.014). A functional role of the apolipoprotein E-E4 isoform in the pathogenesis of late-onset familial Alzheimer dise is suggested.
Apolipoprotein E (APOE, gene; ApoE, protein) is a plasma protein involved in cholesterol transport (1) . ApoE is produced and secreted in the central nervous systram by astrocytes (2-4). Brain contains large quantities ofAPOE mRNA, second only to the liver (5) . ApoE synthesis is increased following injury and is implicated in the growth and repair of the nervous system during development or after injury. In the peripheral nervous system, the synthesis of ApoE increases 250-to 350-fold within 3 weeks of sciatic nerve crush, and ApoE constitutes 5% of the total soluble extracellular protein (2, 6) . After crush injury to the central nervous system optic nerve, ApoE is bound to the degenerating optic tracts and to the retino-recipient layers of the lateral geniculate nucleus and the superior colliculus (7) . ApoE is also increased in several chronic neurodegenerative diseases. In Alzheimer disease, ApoE is bound to extracellular senile plaques, to intracellular neurofibrillary tangles, and at sites of cerebral vessel congophilic angiopathy (8) . ApoE is also bound in the amyloid plaques of another dementing degenerative disease, Creutzfeld-Jakob disease (8) . The amyloid deposits in Creutzfeld-Jakob disease contain the prion protein, not the 3A4 peptide in Alzheimer disease (9) . APOE mRNA is increased severalfold in the brain of patients with Alzheimer disease and in the brain of animals with scrapie (10), a transmissible disease in animals that is similar to CreutzfeldJakob disease in humans and also exhibits prion protein plaques (9 proteins are eluted from both immobilized peptides with 5% SDS (Fig. 1, lanes 2) ; by 4 M urea (lanes 3); or by 6 M guanidine hydrochloride (lanes 4). Guanidine hydrochloride did not elute ApoE from the 3A4-(12-28) peptide but did elute virtually all the ApoE bound to the even-hydropathy control peptide ( Fig. 1 Lower, lanes 4) .
Binding of ApoE to various immobilized peptides is shown in Fig. 2 . ApoE in CSF remained bound to immobilized (A4-(1-40), fA4-(1-28) , andj'A4-(12-28) after incubation and washing with phosphate-buffer saline plus 5% SDS. The even-hydropathy peptide contains the same amino acids as ,(A4-(12-28) but has a hydropathic profile different from ,BA4-(12-28) (Fig. 3) . ApoE did not bind to this immobilized peptide (Fig. 2 Lower) . The 12-28 hydropathic mimic peptide contains different amino acids than ,BA4-(12-28) but has a hydropathy profile very similar to /A4-(12-28) (Fig. 3) . This peptide also bound ApoE after washing with phosphatebuffered saline plus 5% SDS (Fig. 2) .
Antiserum to ApoE stained amyloid plaques in tissues from Alzheimer disease patients and an aged lemur (Fig. 4 B and  E) . This immunolocalization was observed even at the'highest dilutions of antiserum and was very intense compared with control sections (Fig. 4A ). Plaques were the last structures to lose immunopositivity. Formic acid pretreatment increased ApoE immunoreactivity of amyloid plaques, similar to the effect of formic acid on fA4 immunoreactivity. ApoE immunoreactivity (Fig. 4B) closely imitated the distribution of 3A4 amyloid (Fig. 4C) , even being observed near glial processes (Fig. 4 B and C, arrowheads) . In addition, intraneuronal staining was observed, which may represent staining of neurofibrillary tangles (8) or early degeneration of neurons (Fig. 4 D-F) . Immunohistochemical identification of ApoE surrounding blood vessels was similar in appearance to BA BA BA E. H. ,3A4 amyloid immunostaining of vascular amyloid deposits (Fig. 4F ).
There are three major isoforms of ApoE identified by amino acid sequencing, designated ApoE-E3, ApoE-E4, and ApoE-E2. The two uncommon isoforms, E2 and E4, vary from the common E3 isoform by the substitution of one amino acid (1). ApoE-E4 contains an arginine at residue 112, whereas E3 has a cysteine. ApoE-E2 contains a cysteine at residue 158, whereas E3 has an arginine. There are other rare isoforms (1). PCR-based restriction isotyping ofAPOE alleles has been developed for use in population'studies (13, 14) . Association studies ofAPOE alleles using DNA samples from one randomly selected familial Alzheimer disease patient from each of 30 families and from 91 age-matched unrelated controls showed that the frequency of the APOE-e4 allele in the 30 patients (0.50 ± 0.06) differed significantly from the frequency found in the 91 controls (0.16 ± 0.03; Z = 2.44, P = 0.014). The allele frequency of APOE-E4 found in our control population was similar to that found in a larger population study (20) . APOE-e4 frequency was similar for all 83 tested Alzheimer disease patients in the 30 families, indicating that the random sample used in the association analysis accurately represented the e4 allele frequency in the families (Table 1 ). and systemic amyloid. The latter authors suggested that ApoE may act as a molecular chaperone, defined as "unrelated proteins that mediate ,B-pleated amyloid formation of polypeptide fragments." Our combined peptide binding data, immunochemistry, and allele association analyses suggest a more integrated role of ApoE in (3A4 metabolism and targeting in Alzheimer disease.
ApoE may be a common denominator in either the pathogenesis or the cellular response of several dementing dis- whether the significant results indicated association rather than true linkage (15) . The association of the APOE-e4 allele with familial Alzheimer disease was significantly increased compared to the population controls and is consistent with prior analyses.
The finding that the APOE-e4 allele is associated with familial Alzheimer disease patients has two major implications. First, there may be allele-specific functions that contribute to the molecular mechanism ofthe disease expression. Second, there could also be another intragenic polymorphism on an APOE-e4 background that confers susceptibility to Alzheimer disease. A similar mechanism has been described for fatal familial insomnia (23) and one form of CreutzfeldJakob disease (24, 25) . Two distinct phenotypes share the same prion protein codon-178 mutation, with disease expression determined by the inheritance of another intragenic prion polymorphism (25) .
Another report (22) will describe the status ofAPOE alleles in sporadic Alzheimer disease. With the recent appreciation that 3A4 amyloid is a normal extracellular product in many cell types (26) , the discovery of specific interactions between ApoE and ,SA4 could define additional mechanisms of Alzheimer disease pathogenesis. It is intriguing that antibodies to ApoE stain both intracellular and extracellular structures in Alzheimer disease, Creutzfeld-Jakob disease, and a primate model ofPA4 amyloidosis. ApoE functions to transport lipids into the cell. A function involving the binding, transport, and targeting of 83A4 (or other peptides) may link the diagnostic lesions and genetic susceptibility, suggesting a functional role for ApoE isoforms in the mechanism of Alzheimer disease pathogenesis.
